{"title":"10-Week Conducting and Managing Oncology Clinical Trials","description":"\u003cp class=\"header-block-grey\"\u003eCourse Description\u003c\/p\u003e\u003cp\u003eThis\n 10-Week series provides an in-depth look at how oncology trials are conducted\n    and how they differ from other clinical trials. For example, oncology can be\n    more difficult due to the complexity of the disease and its treatments, number\n    of prior therapies, or proper staging of the disease and other criteria for\n    trial eligibility. Each module will address a specific oncology knowledge area\n    to improve the clinical researcher’s knowledge. This course is for the clinical\n    research professional who is either in oncology clinical research seeking\n    education to improve their understanding of oncology trials or for those who\n    would like to enter the field or who are assigned to these trials but who have\n    little or no experience in oncology trials.\u003c\/p\u003e\u003cp\u003ePrior to the start of the course, participants will receive their login\ncredentials and links to access and download the many class resources\nand class meeting links. Upon course completion, participants will be\nprovided training certificates. In order to receive accreditation CEUs,\nparticipants are required to pass both a mid-term and final exam. Upon\ncompletion of the exams, CEU certificates will be provided.\u003c\/p\u003e\u003cp class=\"header-block-grey\"\u003eLearning Objectives\u003c\/p\u003e\u003cul type=\"disc\"\u003e\n\u003cli\u003eDefine best practices for understanding the\n        oncology trial, including the basics of phase I, phase II, and phase III\n        trials\u003c\/li\u003e\n\u003cli\u003eIdentify the parts of an oncology\n        protocol and types of therapies used in oncology trials\u003c\/li\u003e\n\u003cli\u003eDefine the future new agent\n        therapies in cancer research and the role of traditional therapies\u003c\/li\u003e\n\u003cli\u003eDefine and compare RECIST 1.1,\n        iRECIST, and PERCIST\u003c\/li\u003e\n\u003cli\u003eExamine why adjudication of tumor\n        assessment is used in oncology clinical trials\u003c\/li\u003e\n\u003cli\u003eExamine challenges in adverse event\n        reporting: Common Terminology Criteria for Adverse Events (CTCAE)\u003c\/li\u003e\n\u003cli\u003eIdentify how the clinical researcher\n        plays a significant role in the field of oncology research\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"header-block-grey\"\u003eCourse Outline\u003c\/p\u003e\u003cul type=\"disc\"\u003e\n\u003cli\u003eModule 1: Design and Conduct of Oncology Trials:\n        From Non-Clinical Through Pivotal Trial Phases\u003c\/li\u003e\n\u003cli\u003eModule 2: The Oncology Protocol:\n        Dissection of the Protocol for Better Understanding, Training, and\n        Compliance\/Adherence By Research Teams\u003c\/li\u003e\n\u003cli\u003eModule 3: Defining Types of\n        Therapies: Adjuvant, Neoadjuvant, Maintenance, and the Rationale for\n        Combination Therapy; Use of Surgical or Radiation Therapy in the Treatment\n        of Cancers\u003c\/li\u003e\n\u003cli\u003eModule 4: Understanding Future New\n        Agent Therapies in Cancer Research and Some that are Already Here: The\n        Future of Immunotherapy and Beyond While Maintaining the Role of\n        Traditional Therapies\u003c\/li\u003e\n\u003cli\u003eModule 5: Oncology Endpoints:\n        Making Sure Everyone Understands How, When, and Why Endpoints Matter, What\n        the Path to Approval Is, and What the New Approval Designations Mean\u003c\/li\u003e\n\u003cli\u003eModule 6: Understanding Why RECIST\n        1.1, iRECIST, or PERCIST is Being Used in the Clinical Trial You Are\n        Assigned\/Manage\u003c\/li\u003e\n\u003cli\u003eModule 7: Adverse Event Reporting\n        in Oncology Clinical Trials: Considerations for Successful Adverse Event\n        Reporting the Importance of CTCAE\u003c\/li\u003e\n\u003cli\u003eModule 8: Understand Oncologic\n        Emergencies, Supportive Care, and Alternative\/Complementary Medicine and\n        How These Contribute to or Cause Adverse Events\u003c\/li\u003e\n\u003cli\u003eModule 9: Recruitment Challenges:\n        Define the Challenges and Methods for Improvement, Including the Role and\n        Effect of Expanded Access Programs and Investigator-Initiated Trials\u003c\/li\u003e\n\u003cli\u003eModule 10: Putting It All Together\n        and the Role of the Clinical Researcher. How Your Role Impacts the Outcome\n        of Clinical Trials and What Can You Do to Improve the Outcome\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"header-block-grey\"\u003eWho Should Attend\u003c\/p\u003e\u003cul type=\"disc\"\u003e\n\u003cli\u003eClinical Project Managers\/Clinical Project\n        Leaders\u003c\/li\u003e\n\u003cli\u003eClinical Trial Managers\u003c\/li\u003e\n\u003cli\u003eClinical Operations Managers\u003c\/li\u003e\n\u003cli\u003eClinical Safety Team Personnel\u003c\/li\u003e\n\u003cli\u003eClinical Research Associates\u003c\/li\u003e\n\u003cli\u003eClinical Research Coordinators\u003c\/li\u003e\n\u003cli\u003eClinical Trial Assistants\u003c\/li\u003e\n\u003cli\u003eData Managers\u003c\/li\u003e\n\u003cli\u003eClinical Research Personnel seeking\n        to learn about oncology clinical trials\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eNOTE: This course is for individual registrants only and does\n    not allow for group training.\u003c\/p\u003e\u003cp class=\"abstract\"\u003e\u003cspan class=\"bold\"\u003eWhat participants say about Barnett's 10-Week courses\n        ...\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e“Great course! Instruction is expertly led and engaging. I\n    will recommend Barnett to any colleague and will seek out topics for my own\n    future training and professional development needs.”\u003c\/p\u003e\u003cp\u003e\"The course has been so incredibly helpful thus far...I\n    look forward to Thursday evenings!\"\u003c\/p\u003e\u003cp\u003e“This class exceeded my expectations of an online learning\n    experience. The instructor was knowledgeable, came equipped with great examples\n    to keep the class interesting and is a strong presenter. Thank you!”\u003c\/p\u003e\u003cp class=\"header-block-grey\"\u003eInstructor\u003c\/p\u003e\u003cp class=\"bold-italic\"\u003e\u003cb\u003e\u003ci\u003eThe\n course will be led by one of the following instructors:\u003c\/i\u003e\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003eDenis R. Miller, M.D.\u003c\/p\u003e\u003cp\u003eLinda Patricia Miller, M.D.\u003c\/p\u003e\u003cp\u003e\u003cspan class=\"purple-link\"\u003e\u003ca href=\"https:\/\/www.barnettinternational.com\/instructor-biographies\/\" title=\"Click here for complete trainer biographies\"\u003eClick here for complete trainer\n            biographies\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp class=\"header-block-grey\"\u003e\u003cspan class=\"purple-link\"\u003e\u003cb\u003e\u003ci\u003eCourse\n Length and Time\u003c\/i\u003e\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e10 weeks for 3 hours each week.\u003c\/p\u003e\u003cp class=\"header-block-grey\"\u003eRegistration Fees\u003c\/p\u003e\u003cp\u003e$2,295 by Early Bird Deadline\u003c\/p\u003e\u003cp\u003e$2,495 after Early Bird Deadline\u003c\/p\u003e\u003cp\u003eThis course is for individual\n    registrants only and does not allow for group training.\u003c\/p\u003e\u003cp\u003eAll participants are eligible for\n    “Certificates of Attendance,” and accreditation, provided that accreditation\n    requirements are met.\u003c\/p\u003e\u003cp class=\"header-block-grey\"\u003eAccreditation Information\u003c\/p\u003e\u003cp\u003eBarnett International is accredited by the Accreditation\n    Council for Pharmacy Education as a provider of continuing pharmacy\n    education.  Participants will receive 30 hours (3.0 CEUs) of\n    continuing education credit for full participation, including the completion of\n    a mid-term exam, final exam, and program evaluation.  Barnett\n    International will issue a receipt of completion for earned CEUs within three\n    weeks of program completion.  ACPE#: 0778-0000-23-041-L99-P. Released: 9\/23.\u003c\/p\u003e\u003cp align=\"center\"\u003eHold\n this course at your company! For more information, contact Naila Ganatra at +1\n    215.413.2471.\u003c\/p\u003e","products":[],"url":"https:\/\/www.barnettinternational.com\/collections\/10-week-conducting-and-managing-oncology-clinical-trials.oembed","provider":"Barnett International ","version":"1.0","type":"link"}